Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MYT Netherlands (NY: MYTE )

9.335 +0.065 (+0.70%)
Streaming Delayed Price Updated: 1:40 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MYT Netherlands

< Previous 1 2 3 4 Next >
Q2 FY23 Results: Mytheresa Reports GMV Growth of 8% in Q2 FY23 and Strong Profitability of 9% Adjusted EBITDA Margin Despite Significant Macro-Economic Headwinds
From MYT Netherlands Parent B.V.
Via Business Wire
Earnings Outlook For MYT Netherlands Parent
Via Benzinga
Mytheresa Announces Second Quarter Fiscal Year 2023 Earnings Release and Conference Call; Participating in Upcoming Investor Conferences
From MYT Netherlands Parent B.V.
Via Business Wire
Q1 FY23 Results: Mytheresa accelerates growth with GMV up 21% in Q1 FY23 and confirms full FY23 GMV & Adjusted EBITDA guidance
From MYT Netherlands Parent B.V.
Via Business Wire
4 Analysts Have This to Say About MYT Netherlands Parent
MYT Netherlands Parent (NYSE:MYTE) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Where MYT Netherlands Parent Stands With Analysts
Analysts have provided the following ratings for MYT Netherlands Parent (NYSE:MYTE) within the last quarter: 
Via Benzinga
Mytheresa Clocks 7.7% Sales Growth In Q4
Via Benzinga
Earnings Scheduled For February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
Gainers Viomi Technology Co (NASDAQ:VIOT) stock increased by 16.1% to $0.93 during Friday's regular session. The market value of their outstanding shares is at $64.4 million. 
Via Benzinga
Analyst Ratings for MYT Netherlands Parent
Over the past 3 months, 5 analysts have published their opinion on MYT Netherlands Parent (NYSE:MYTE) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Mytheresa Announces First Quarter Fiscal Year 2023 Earnings Release and Conference Call; Participating in Upcoming Investor Conferences
From MYT Netherlands Parent B.V.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session
Gainers Shift Technologies (NASDAQ:SFT) shares increased by 5.0% to $0.69 during Thursday's after-market session. The market value of their outstanding shares is at $58.8 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
What 4 Analyst Ratings Have To Say About MYT Netherlands Parent
MYT Netherlands Parent (NYSE:MYTE) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Keybanc Slashes PT On This Stock By 50%, Plus This Analyst Predicts $100 For PayPal
Susquehanna lowered the price target for PayPal Holdings, Inc. (NASDAQ: PYPL) from $115 to $100. PayPal shares fell 2.4% to $92.73 in pre-market trading. 
Via Benzinga
Q4 and Full FY22 Results: Mytheresa Accelerates Growth in Q4 and Concludes the Full Fiscal Year With a GMV Growth of 21.3%, a Two-Year GMV Growth of 66.3% and a Record Profitability of 9.6% Adjusted EBITDA Margin
From Mytheresa
Via Business Wire
Earnings Scheduled For September 15, 2022
Companies Reporting Before The Bell • Boqii Holding (NYSE:BQ) is estimated to report earnings for its first quarter. 
Via Benzinga
Preview: MYT Netherlands Parent's Earnings
MYT Netherlands Parent (NYSE:MYTE) is set to give its latest quarterly earnings report on Thursday, 2022-09-15. Here's what investors need to know before the announcement. Analysts estimate that MYT... 
Via Benzinga
Mytheresa Announces Fourth Quarter and Full Fiscal Year 2022 Earnings Release and Conference Call
From MYT Netherlands Parent B.V.
Via Business Wire
What 5 Analyst Ratings Have To Say About MYT Netherlands Parent
Over the past 3 months, 5 analysts have published their opinion on MYT Netherlands Parent (NYSE:MYTE) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
Q3 FY22 Results: Mytheresa reports GMV growth of 13.2% in Q3 FY22, a 67% two-year growth, stable profitability and targets strong full fiscal year 2022
From MYT Netherlands Parent B.V.
Via Business Wire
Mytheresa to Participate in Upcoming Investor Conferences
From MYT Netherlands Parent B.V.
Via Business Wire
Mytheresa Announces Third Quarter Fiscal Year 2022 Earnings Release and Conference Call
From MYT Netherlands Parent B.V.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2022
Upgrades 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Gainers Trxade Health (NASDAQ:MEDS) shares increased by 18.0% to $2.76 during Tuesday's regular session. Trxade Health's stock is trading at a volume of 16.1... 
Via Benzinga
UBS Upgrades This Luxury E-Commerce Company - Read Why
UBS analyst Kunal Madhukar upgraded MYT Netherlands Parent BV (NYSE: MYTE) (Mytheresa) to Buy from Neutral. Madhukar said he is optimistic about the company... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022
Upgrades For iRobot Corp (NASDAQ:IRBT), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. In the fourth quarter, iRobot showed an EPS of $1.... 
Via Benzinga
Mytheresa to Participate in Upcoming Investor Conferences
From MYT Netherlands Parent B.V.
Via Business Wire
Expert Ratings For MYT Netherlands Parent
Within the last quarter, MYT Netherlands Parent (NYSE:MYTE) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish... 
Via Benzinga
56 Biggest Movers From Yesterday
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.